BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25611886)

  • 21. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination.
    Di Lello FA; Blejer J; Alter A; Bartoli S; Vargas F; Ruiz R; Galli C; Blanco S; Gallego S; Fernández R; Martínez AP; Flichman DM
    Vaccine; 2020 Mar; 38(12):2678-2682. PubMed ID: 32061386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
    Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
    Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
    Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
    Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
    Baruti K; Lentz K; Anderson M; Ajibola G; Phinius BB; Choga WT; Mbangiwa T; Powis KM; Sebunya T; Blackard JT; Lockman S; Moyo S; Shapiro R; Gaseitsiwe S
    PLoS One; 2020; 15(8):e0237252. PubMed ID: 32764801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
    Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
    J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Experiment of Nature: HBV-naive Recipients Receiving Liver Grafts With HBV Core Antibody-positive Donors Without Antiviral Prophylaxis.
    Fallahzadeh MA; Trotter JF
    Transplantation; 2020 Aug; 104(8):e245-e246. PubMed ID: 32732858
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
    McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
    Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study.
    Yang YT; Huang AL; Zhao Y
    Vaccine; 2019 Jan; 37(3):458-463. PubMed ID: 30527659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States.
    Kim HS; Rotundo L; Yang JD; Kim D; Kothari N; Feurdean M; Ruhl C; Unalp-Arida A
    J Viral Hepat; 2017 Nov; 24(11):1052-1066. PubMed ID: 28581638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.
    Ji Z; Wang T; Shao Z; Huang D; Wang A; Guo Z; Long Y; Zhang L; Su H; Zhang Q; Yan Y; Fan D
    PLoS One; 2014; 9(5):e97474. PubMed ID: 24832483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of antibody persistence after a four-dose primary hepatitis B vaccination and anamnestic immune response in children under 6 years.
    Tfifha M; Kacem S; Ben Rejeb M; Naija S; Boujaafar N; Abroug S; Trabelsi A
    J Med Microbiol; 2019 Nov; 68(11):1686-1693. PubMed ID: 31592765
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.
    Odusanya OO; Alufohai FE; Meurice FP; Wellens R; Weil J; Ahonkhai VI
    Int J Infect Dis; 2005 May; 9(3):139-43. PubMed ID: 15840454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
    Scognamiglio P; Girardi E; Fusco M; Piselli P; Spena SR; Maione C; Pisanti FA; Serraino D;
    BMC Infect Dis; 2009 Jun; 9():86. PubMed ID: 19500412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.